Volume 8, Issue 2 (7-2010)                   IJRM 2010, 8(2): 70-75 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ganaie J A, Shrivastava V K. Effects of gonadotropin releasing hormone conjugate immunization and bioenhancing role of Kamdhenu ark on estrous cycle serum estradiol and progesterone levels in female Mus musculus. IJRM 2010; 8 (2) :70-75
URL: http://ijrm.ir/article-1-176-en.html
1- Endocrinology Labratory, Department of Biosciences, Barkatullah University, Bhopal-462026 (M.P.) India
2- Endocrinology Labratory, Department of Biosciences, Barkatullah University, Bhopal-462026 (M.P.) India , vinoyks2001@yahoo.com
Full-Text [PDF 217 kb]   (424 Downloads)     |   Abstract (HTML)  (2195 Views)
Full-Text:   (339 Views)
Introduction
The  gonadotropin   releasing  hormone (GnRH) is a  key  regulator  of   reproductive   functions   in mammals,    acting    mainly    at    the    level    of
hypothalmo-hypophysis axis. The decapeptide GnRH is synthesized in the neurons of the hypothalamus and released into the portal circulation where it interacts with GnRH receptors on the gonadotrope cells in the anterior pituitary (1). Stimulation of the GnRH receptor is essential for the secretion of LH (luteinizing hormone) and FSH (follicle stimulating hormone), which, in turn, are required for steroidogenesis, gametogenesis and cyclicity (1).
     Because of this central role in reproduction, GnRH peptide analogs have found therapeutic applications in controlling fertility, cryptorchidism, polycystic ovarian syndrome, leiomyomata, endometriosis, acute intermittent porphyria, and breast and prostate cancer (2-3), and show promise as new generation contraceptives for males and females. There is a need for alternative and cost-effective approaches to regulate gonadal activity, particularly in wild and domestic animals and in chronic diseases in man.
     Active immunization of various mammals to GnRH, has been shown to lead in the case of males to testicular regression, reduction of testosterone secretion and cessation of spermatogenesis, while in the case of females, loss of cycling and ovarian regression (4-5).
     Immunoneutralization of GnRH by vaccination with synthetic peptides is effective in regulating fertility in animals (6,7) and in the treatment of prostate cancer in males (8) and they have therapeutic potential in sex hormone-dependent neoplasms in females (9). Kamdhenu ark (distilled cow urine) has been reported as a strong immunomodulator and bioenhancer by various workers (10, 11).
     In present investigation our aim is to evaluate the impacts of immunization with GnRH-BSA conjugate on estrous cycle and reproductive hormones (estradiol, progesterone) in female mice and the modulatory role of Kamdhenu ark after the immunization.
 
Materials and methods
      Sixty sexually mature disease free female mice weighing 30±5 gr were used for this experimental investigation. The animals were divided into three groups of twenty each. Group I served as control, fed with standard mice feed and water ad libitum, while the animals of group II were immunized four times (Day 1, 28, 56, 84) with 50 µg GnRH-BSA conjugate (Sigma Aldrich) [100 µl phosphate buffered solution (0.01 N) and emulsified with an equal volume i.e., 100 µl  Freund´s adjuvant] up to 120 days. However, group III was supplemented with Kamdhenu ark (100 ppm) orally along with GnRH-BSA conjugate immunizations. Vaginal smears were prepared daily in the afternoon in all the groups from day 1st to 120th day and stained with Giemsa solution to observe different stages of estrous cycle (12). Estradiol and progesterone levels in blood serum were estimated after 30, 60, 90 and 120 days along with control by using ELISA reader (Thermo multiskan lab system) adopting the methodology of Wisdom (1976) (13). Five animals from each group at different intervals were sacrificed and blood was collected through cardiac puncture and processed for serum preparation.
 
Statistical analysis
     Results of the experiment were expressed as mean and standard error of mean of different groups.
     The differences between the mean values were evaluated by Student’s t test. The values for p<0.001 were considered as highly significant.
 
Results
     Irregular and prolonged estrous cycle was observed in all the experimental groups as compared to control group. The normal estrous cycle lasts for 4-5 days which was observed in the control group (Figure 1). But the animals immunized with GnRH-BSA showed regular estrous cyclicity initially up to 13th day and then started showing irregular and prolonged estrous cycle with a complete diestrus stage after 65th day onward (Figure 2). While, the animals supplemented  Kamdhenu ark with GnRH-BSA also showed regular cyclicity initially i.e. up to 19th day but in later they showed more interrupted estrous cycle with a complete diestrus stage after 55th day of treatments (Figure 3). Along with this, it has been noticed that estradiol and progesterone levels were lowered significantly throughout the experiments i.e. 30, 60, 90 and 120 days in immunized and Kamdhenu ark treated animals as compared to control group. While, these effects were more prominent and severely observed in the later part of the experiment especially supplemented with Kamdhenu ark (Table I; Figures 4 and 5).


Figure 1. Estrous cycle in control female mice (Mus musculus). [Phases of estrous cycle: P= Proestrus; E= Estrus; M= Metaestrus; D= Diestrus]
 

Figure 2. Estrous cycle in GnRH-BSA immunized female mice (Mus musculus). [Phases of estrous cycle: P= Proestrus; E= Estrus; M= Metaestrus; D=Diestrus]


Figure 3. Estrous cycle in GnRH-BSA immunized and Kamdhenu ark supplemented female mice (Mus musculus).  [Phases of estrous cycle; P= Proestrus, E=Estrus, M= Metaestrus, D= Diestrus]


Figure 4.  Estradiol estimation (pg/ml) in serum of GnRH-BSA immunizwd, GnRH-BSA immunized+Kamdhenu ark supplemented and control female mice (Mus musculus).
± SEM of five animals.
*= Significantly different (p< 0.05) from the control by Student’s ‘t’ test.
*** = Highly significant (p< 0.001) from the control by Student’s ‘t’ test.


Figure 5. Progestrone estimation (ng/ml) in serum of GnRH-BSA immunized, GnRH-BSA immunized + Kamdhenu ark supplemented and control female mice (Mus Musculus).
± SEM of five animals.
*= Significantly different (p< 0.05) from the control by Student’s ‘t’ test.
*** = Highly significant (p< 0.001) from the control by Student’s ‘t’ test.
 

Table I. Hormonal estimations in GnRH-BSA immunized, GnRH-BSA+kamdhenu ark supplemented and control female mice, Mus musculus.


Discussion
     In the pituitary, GnRH binds to the GnRH receptors on the gonadotropic cells to stimulate the release of FSH and LH to the circulation. The pulsatile secretion pattern of GnRH induces the cyclic release of LH and to a lesser extent of FSH. In female mammals, FSH induces follicle growth and subsequently estradiol and inhibin secretion by the granulose cells. After ovulation the luteinised granulosa and the theca cells start to produce the high levels of progesterone. Because of relatively lower immunogenicity of the GnRH peptide, a number of adjuvants, carrier proteins, recombinant peptides and immunomodulators have been designed to modulate the immunogenecity of the GnRH peptide (14-16). Production of antibodies to gonadotropin releasing hormone was found to be associated with gonadal atrophy in mammals after GnRH immunization (17-19).  Long term effects of GnRH immunization in white tailed female deer including reduced fawning rates, altered estrous behavior and reduced concentration of progesterone has been reported by Lowell et al (2003) (20).
     Tshewang et al (2008) also reported suppressed ovarian activity along with irregular estrous behavior and decreased progesterone and androstenedione concentration in Australian stock horse fillies after GnRH immunization (21). Kamdhenu ark has been reported to enhance the immunogenecity of different antigens in mammals by various workers (22-23). Besides this, Kamdhenu ark acts as a bioenhancer and increases the efficacy of the antibiotics against infection agents. In our study it has been noticed that the GnRH-BSA conjugate modulate the hormonal levels in female mice. GnRH-BSA immunizations led to irregular estrous cyclicity and lowered estradiol and progesterone concentrations. These effects were more effective in later part of the experiment modulated through Kamdhenu ark supplementation.
     All these results suggested that the efficacy of antibodies were raised after GnRH-BSA immunizations against the biologically active GnRH was more after supplementation of Kamdhenu ark resulted declined hormonal levels and alterations of the estrous cycle in female mice.
 
Conclusion
     Our results concluded that the GnRH-BSA conjugate has a deleterious effect on the reproductive hormones and estrous cycle of female mice and Kamdhenu ark acts as a bioenhancer in immunization efficacy to modulate these effects.  
 
Acknowledgement
     The financial support for this experimental investigation was provided by Department of Biosciences, Barkatullah University, Bhopal M.P. (India). The authors want to thank Prof. Meenakshi Benerjee (Prof. and H.O.D.), Department of Biosciences, for providing the facilities making these experiments possible.
 
Type of Study: Original Article |

References
1. Fink G. Gonadotropin secretion and its control. In: Knobil E, Neill JD, eds. The physiology of reproduction. New York: Raven Press 1988; 1349–1377.
2. Millar RP, King JA, Davidson JS, Milton RC. Gonadotrophin-releasing hormone-diversity of functions and clinical applications. S Afr Med J 1987; 72: 748–755.
3. Casper RF. Clinical uses of gonadotropin-releasing hormone analogues. Can Med Assoc J 1991; 144:153–158.
4. Ladd A, Tsong YY, Walfield AM, Thau R. Development of antifertility vaccine for pets based on active immunization against luteinizing hormone-releasing hormone. Biol Reprod 1994; 51: 1076-1083. [DOI:10.1095/biolreprod51.6.1076]
5. Prevendiville DJ. Immunization of Heifers against gonadotropin releasing hormone: Antibody titres, Ovarian function, Body growth and Carcass characteristics. J Anim Sci 1995; 73: 2382-2389. [DOI:10.2527/1995.7382382x]
6. Ghosh S, Jackson DC. Antigenic and immunogenic properties of totally synthetic peptide-based anti-fertility vaccines. Int Immunol 1999; 11:1103–1110. [DOI:10.1093/intimm/11.7.1103]
7. Turkstra JA. Active immunization against gonadotropin releasing hormone, an active tool to block the fertility in mammals. PhD thesis, Utrecht University, Netherlands 2005; 13-50.
8. Talwar GP. Vaccines for control of fertility and hormone-dependent cancers. Immunol Cell Biol 1997; 75: 184–189. [DOI:10.1038/icb.1997.26]
9. Jacobs E, Watson SA, Michaeli D, Ellis IO, Robertson JF. Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7 human breast cancer xenografts. Br J Cancer 1999; 80: 352–359. [DOI:10.1038/sj.bjc.6690362]
10. Chauhan RS. Natural therapy with panchgavya. Kisan Bharti 2001; 32: l27-128.
11. Garg N, Chauhan RS. Kamdhenu ark and humoral immunity in rat. National Symposium on Molecular Biology in India- A posgraduate update, January 18, 2003. Gwalior.
12. Zarrow M, Yochim J, McCarthy J, eds. Experimental Endocrinology: A Sourcebook of Basic Techniques. New York: Academic Press, 1964.
13. Wisdom GB. Direct immunoenzymatic determination of estradiol and progesterone in serum or plasma. Clin Chem 1976; 22: 1243-1255.
14. Hsu CT, Ting CY, Ting CJ, Chen TY, Lin CP, Whang-Peng J, Hwang J. Vaccination against gonadotropin-releasing hormone (GnRH) using toxin receptor-binding domain-conjugated GnRH repeats. Cancer Res 2000; 60, 3701–3705.
15. Talwar GP. Chimeric recombinant antibodies against hCG and LHRH for control of fertility and cancers. In Talwar GP and Sood OP (eds) Therapeutic Antibodies. Ranbaxy Science Foundation 2003; 9: 99–108.
16. Ferro VA, Costa R, Carter KC, Harvey MJ, Waterston MM, Mullen AB, et al. Immune responses to a GnRH-based anti-fertility immunogen, induced by different adjuvants and subsequent effect on vaccine efficacy. Vaccine 2004; 22: 1024–1031. [DOI:10.1016/j.vaccine.2003.08.043]
17. Arimura A, Sato H, Kumasaka T, Wordrobe RB, Debeljuk L, Dunn J, Schally AV. Production of antiserum to LH-releasing hormone (LHRH) associated with gonadal atrophy in rabbits; Development of radioimmunoassay for LHRH. Endocrinology 1973; 93: 1092-1103. [DOI:10.1210/endo-93-5-1092]
18. Fraser HM, Gunn A, Jeffcoate SL, Holland DT. Effect of active immunization to luteinizing hormone releasing hormone on serum and pituitary gonadotropins, testes and accessory sex organs in the male rat. J Endocrino 1974; 63: 399-406. [DOI:10.1677/joe.0.0630399]
19. Giri DK, Chaudhuri MK, Jayashankar R, Neelaram GS, Jayaraman S, Talwar GP. Histopathological changes in reproductive organs of male Wistar rats following active immunization against GnRH. Exp Mol Pathol 1990; 52: 54-62. [DOI:10.1016/0014-4800(90)90058-L]
20. Lowell AM, Brad EJ. Immunocontraception of White-Tailed Deer with GnRH Vaccine. Am J Reprod Immunol 2000; 44: 266-274. [DOI:10.1111/j.8755-8920.2000.440503.x]
21. Tshewang U, Dowsett KF, Knott LM, Trigg TE. Preliminary study of ovarian activity in fillies treated with a GnRH vaccine. Aust Vet J 2008; 75: 663-667. [DOI:10.1111/j.1751-0813.1997.tb15366.x]
22. Kumar R, Chauhan RS. A comparatives study on immunomodulatory effects of Kamdhenu ark Vasant kusumakar in mice. Journal of Immunology and Immunopathology 2004; 4: 104-106.
23. Garg N, Kumar A, Chauhan RS. Assessing the effect of cow urine on immunity of white leghorn layers, International society for animal hugges (ISAH) Warsa, Poland 2005; 2: 81-83.

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb